Related Experiment Videos
[Rhabdomyosarcoma of the prostate]
Hinyokika Kiyo. Acta Urologica Japonica
|January 1, 1986
Summary
This case study details a rare prostate rhabdomyosarcoma in a 56-year-old man. Despite chemotherapy, the aggressive cancer led to metastatic disease and death within four months.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Rhabdomyosarcoma is a rare malignancy, particularly in adults, and its occurrence in the prostate is exceptionally uncommon.
- Prostate rhabdomyosarcoma can present with non-specific symptoms, potentially delaying diagnosis.
Observation:
- A 56-year-old male presented with anal pain and dysuria, raising suspicion for a prostate tumor.
- Rectal examination suggested a prostate mass, and imaging revealed widespread metastatic lesions in the lungs and liver.
- Needle biopsy confirmed the diagnosis of rhabdomyosarcoma of the prostate.
Findings:
- The patient received Etoposide chemotherapy with minimal response.
- Subsequent VAC (Vincristine, Dactinomycin, Cyclophosphamide) therapy resulted in temporary improvement.
- The patient's condition deteriorated, and he died 4 months after initial admission due to the aggressive nature of the disease.
Implications:
- This case highlights the challenges in diagnosing and treating rare adult prostate malignancies.
- Prostate rhabdomyosarcoma, though infrequent, should be considered in the differential diagnosis of prostate tumors with rapid progression and metastasis.
- Further research into effective therapeutic strategies for this rare cancer is warranted.